SCHEMBL21396765

SCHEMBL21396765

N#Cc1ccc(-n2c3ccccc3c3ccccc32)cc1-c1cccc(-n2c3ccccc3c3ccccc32)n1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
HPGD P15428 3/20 0.36
LMNA P02545 1/20 0.36
MAPK1 P28482 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
KDM4E B2RXH2 4/20 0.35
ATM Q13315 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
IMPDH2 P12268 1/20 0.33
AR P10275 4/20 0.32
GAA P10253 3/20 0.32
GLA P06280 2/20 0.32
S1PR4 O95977 1/20 0.32
S1PR1 P21453 1/20 0.32
NR3C1 P04150 1/20 0.32
TGFBR1 P36897 1/20 0.32
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
PTGER4 P35408 1/20 0.31
HTT P42858 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21397161 0.85 KDM4E (0.37) ALDH1A1HPGDMAPK1KDM4EATM
SCHEMBL21396953 0.85 IMPDH2 (0.34) ALDH1A1LMNASMN1; SMN2KDM4EATM
SCHEMBL21396984 0.84 ALDH1A1 (0.40) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL19062211 0.82 KDM4E (0.47) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL21396648 0.81 IMPDH2 (0.33) ALDH1A1LMNASMN1; SMN2KDM4EATM
SCHEMBL21396763 0.80 CYP11B1 (0.34) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL21396751 0.80 MAPK1 (0.38) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL23204638 0.78 KDM4E (0.43) ALDH1A1HPGDLMNAMAPK1KDM4E
SCHEMBL21131405 0.78 KDM4E (0.43) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2
SCHEMBL21131408 0.78 KDM4E (0.43) ALDH1A1HPGDLMNAMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3543230-B1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO LTD (KR) 2021-05-05 EP disclosed
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-09-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190296247-A1 ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE SLC25A21, SLCO4C1, SLC18A1 ALDH1A1 825/4885HPGD 2339/4885LMNA 1449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.